RxDoctor Payments Data

Rachael Parker, DO

Family Medicine · Des Moines, IANPI 1356788129

Payments from drug & device makers

$973in general payments, 2019–2025

Across 48 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$319
  • Pfizer$159
  • Novo Nordisk$98
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
  • Lilly USA, LLC$65
  • Bayer$48
  • plus $199 from 7 others

What the payments were for

  • Food & beverage$93596%
  • Education$384%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$973 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$31,134
Medicare patients
70
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$83,728
MounjaroTirzepatide49$52,258
FarxigaDapagliflozin Propanediol52$45,157
EliquisApixaban28$24,542
JardianceEmpagliflozin17$16,492
Breo ElliptaFluticasone/Vilanterol18$10,027
Spiriva HandihalerTiotropium Bromide15$8,366
MyrbetriqMirabegron15$7,075
Combivent RespimatIpratropium/Albuterol Sulfate13$6,233
MovantikNaloxegol Oxalate12$5,309
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,203
Advair HfaFluticasone Propion/Salmeterol14$4,647
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen151$3,970
SymbicortBudesonide/Formoterol Fumarate15$3,733
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$2,890

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$98$83,72881 claims
Lilly USA, LLCMounjaro$65$52,25849 claims
AstraZenecaFarxiga, Symbicort$319$48,89067 claims
PfizerEliquis$159$24,54228 claims
GSKBreo Ellipta$14$10,02718 claims
AbbVieSynthroid$40$1,29123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →